100M sars-COV-2 mrna-1273 vaccine doses

Ended Definitive Contract Awarded Last action

Contract number
W911QY20C0100
Awardee
Awarding agency
Obligated
$8,204,906,278

Award facts

Opportunity
  • W911QY20R0043 Solicitation number
  • W911QY-20-c-0100 Limited / Sole Source Justification · Posted Sep 16, 2020
Contract value 100% obligated
$8,204,906,278.12 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Cambridge, MA 02139, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00031 · Covid-19 action: deobligation modification -$220,345
Other Administrative Action P00030 · POP extension $0
Supplemental Agreement for work within scope P00029 · Disposal of expired monovalent moderna doses. $508,000
Other Administrative Action P00028 · Covid-19 vaccine: removing GFP clause $0
Other Administrative Action P00027 · Covid-19 vaccines- dose expiration instructions $0
Other Administrative Action P00026 · Covid-19 vaccines: use of vaccine for research clause $0
Other Administrative Action P00025 · Covid-19 vaccines: rescission of hrpas/dpas rating $0
Definitize Change Order PZ0001 · Covid-19 vaccines: definitization of unpriced change orders issued under modifications P00022 and P00023 for realignment of production to supply pediatric… $17,477,343
Supplemental Agreement for work within scope P00024 · Covid-19 vaccines: extension and expansion of vendor managed inventory sotrage $4,846,476
Change Order P00023 · Covid-19 vaccines: amend unpriced change order to realign production from adult vaccines to pediatric vaccines $10,500,000
Change Order P00022 · Covid-19 vaccine: unpriced change order to pause production and realign manufacturing for pediatric doses. $26,000,000
Supplemental Agreement for work within scope P00021 · Covid-19 vaccines $203,142
Other Administrative Action P00020 $0
Other Administrative Action P00019 · 34M doses $0
Other Administrative Action P00018 · Covid-19 vaccine $0
Other Administrative Action P00017 · Covid-19 vaccines $0
Other Administrative Action P00016 · Covid-19 vaccine $0
Other Administrative Action P00015 $0
Other Administrative Action P00014 · Covid-19 vaccines $0
Other Administrative Action P00013 $0
Other Administrative Action P00012 · 34M doses $0
Other Administrative Action P00011 · Sars-COV-2 mrna-1273 vaccine $0
Other Administrative Action P00010 · ARS-COV-2 mrna-1273 vaccine $0
Other Administrative Action P00009 $0
Other Administrative Action P00008 $0
Exercise an Option P00007 $3,300,000,000
Other Administrative Action P00006 $3,993,663
Other Administrative Action P00005 · Sars-COV-2 mrna-1273 vaccine $0
Exercise an Option P00004 · 100M doses of sars-COV-2 mrna-1273 vaccine $1,650,000,000
Exercise an Option P00003 · Sars-COV2 mrna-1273 vaccine $1,966,598,000
Other Administrative Action P00002 · Mrna-1273 $0
Other Administrative Action P00001 · 100M sars-COV-2 mrna-1273 $0
Original award $1,225,000,000
Show all 33

About this award

Written by GovTribe AI ·

This is a definitive contract awarded by the Joint Program Executive Office for Chemical and Biological Defense, a Defense Department agency, to Moderna, Inc. for 100 million doses of the SARS-CoV-2 mRNA-1273 vaccine. The $8.2 billion firm fixed price contract has an ultimate completion date of August 10, 2023. Moderna, a manufacturer of pharmaceutical goods, has previously received prime and subcontract awards from various government agencies including the Department of Veterans Affairs, Defense Advanced Research Projects Agency, and Department of Health and Human Services for COVID-19 related efforts such as accelerated RNA technology, mRNA-encoded antibodies, and scaled up domestic vaccine manufacturing capacity. This contract award does not appear to have a set-aside designation.

Quick answers

Who was awarded contract W911QY20C0100?

W911QY20C0100 was awarded to Modernatx, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on August 11, 2020.

How much is contract W911QY20C0100 worth?

The government has obligated $8,204,906,278 on W911QY20C0100.

Which agency awarded contract W911QY20C0100?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY20C0100, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911QY20C0100 competed?

The extent of competition for W911QY20C0100 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login